92 related articles for article (PubMed ID: 25394993)
21. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R
Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
[TBL] [Abstract][Full Text] [Related]
22. Isolation and characterization of a large soluble form of fibronectin that stimulates adhesion, spreading, and alignment of mouse erythroleukemia cells.
Scher BM; Mistry SJ; Haque NS; Scher W
Exp Cell Res; 2010 Sep; 316(15):2402-13. PubMed ID: 20547151
[TBL] [Abstract][Full Text] [Related]
23. The hairpin structure of the (6)F1(1)F2(2)F2 fragment from human fibronectin enhances gelatin binding.
Pickford AR; Smith SP; Staunton D; Boyd J; Campbell ID
EMBO J; 2001 Apr; 20(7):1519-29. PubMed ID: 11285216
[TBL] [Abstract][Full Text] [Related]
24. Affinity study of novel gelatin cell carriers for fibronectin.
Van Vlierberghe S; Vanderleyden E; Dubruel P; De Vos F; Schacht E
Macromol Biosci; 2009 Nov; 9(11):1105-15. PubMed ID: 19626719
[TBL] [Abstract][Full Text] [Related]
25. Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.
Danial M; van Dulmen TH; Aleksandrowicz J; Pötgens AJ; Klok HA
Bioconjug Chem; 2012 Aug; 23(8):1648-60. PubMed ID: 22770564
[TBL] [Abstract][Full Text] [Related]
26. Fibronectin cleavage fragments provide a growth factor-like activity for the differentiation of Trypanosoma cruzi trypomastigotes to amastigotes.
Ouaissi A; Cornette J; Schöneck R; Plumas-Marty B; Taibi A; Loyens M; Capron A
Eur J Cell Biol; 1992 Oct; 59(1):68-79. PubMed ID: 1281773
[TBL] [Abstract][Full Text] [Related]
27. Release of elastase from monocytes adherent to a fibronectin-gelatin surface.
Xie DL; Meyers R; Homandberg GA
Blood; 1993 Jan; 81(1):186-92. PubMed ID: 8417788
[TBL] [Abstract][Full Text] [Related]
28. Multimodal imaging demonstrates enhanced tumor exposure of PEGylated FUD peptide in breast cancer.
Lee HJ; Gari MK; Inman DR; Rosenkrans ZT; Burkel BM; Olson AP; Engle JW; Hernandez R; Ponik SM; Kwon GS
J Control Release; 2022 Oct; 350():284-297. PubMed ID: 35995299
[TBL] [Abstract][Full Text] [Related]
29. Rabbit corneal epithelial cells adhere to two distinct heparin-binding synthetic peptides derived from fibronectin.
Mooradian DL; McCarthy JB; Cameron JD; Skubitz AP; Furcht LT
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3034-40. PubMed ID: 1399408
[TBL] [Abstract][Full Text] [Related]
30. Fibronectin aggregation and assembly: the unfolding of the second fibronectin type III domain.
Ohashi T; Erickson HP
J Biol Chem; 2011 Nov; 286(45):39188-99. PubMed ID: 21949131
[TBL] [Abstract][Full Text] [Related]
31. Enhanced expression of a peanut agglutinin reactive O linked oligosaccharide on fibronectins from the synovial fluid of patients with rheumatic disease: quantitation, domain localization, and functional significance.
Carsons S
J Rheumatol; 2002 May; 29(5):896-902. PubMed ID: 12022346
[TBL] [Abstract][Full Text] [Related]
32. Vitronectin alters fibronectin organization at the cell-material interface.
González-García C; Cantini M; Moratal D; Altankov G; Salmerón-Sánchez M
Colloids Surf B Biointerfaces; 2013 Nov; 111():618-25. PubMed ID: 23899674
[TBL] [Abstract][Full Text] [Related]
33. Plasma concentration of biologically active fibronectin and fibronectin bound to gelatin-like material in a porcine model of hyperdynamic endotoxic shock.
Nagelschmidt M; Rink AD; Neugebauer E
Shock; 2000 Oct; 14(4):484-9. PubMed ID: 11049114
[TBL] [Abstract][Full Text] [Related]
34. Fibronectin-targeted FUD and PEGylated FUD peptides for fibrotic diseases.
Lee HJ; Tomasini-Johansson BR; Gupta N; Kwon GS
J Control Release; 2023 Aug; 360():69-81. PubMed ID: 37315694
[TBL] [Abstract][Full Text] [Related]
35. The ins and outs of fibronectin matrix assembly.
Wierzbicka-Patynowski I; Schwarzbauer JE
J Cell Sci; 2003 Aug; 116(Pt 16):3269-76. PubMed ID: 12857786
[TBL] [Abstract][Full Text] [Related]
36. Co-purified gelatinases alter the stability and biological activities of human plasma fibronectin preparations.
Pal S; Chen Z; Xu X; Mikhailova M; Steffensen B
J Periodontal Res; 2010 Apr; 45(2):292-5. PubMed ID: 19909400
[TBL] [Abstract][Full Text] [Related]
37. Characterization of FN-C/H-V, a novel synthetic peptide from fibronectin that promotes rabbit corneal epithelial cell adhesion, spreading, and motility.
Mooradian DL; McCarthy JB; Skubitz AP; Cameron JD; Furcht LT
Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):153-64. PubMed ID: 8425821
[TBL] [Abstract][Full Text] [Related]
38. Interaction of culture-derived macrophages with the fibroblast-binding domain of fibronectin is a necessary but inefficient signal for fibronectin enhancement of CR1-mediated phagocytosis.
Bohnsack JF; Takahashi T; Brown EJ
J Immunol; 1986 May; 136(10):3793-8. PubMed ID: 2939134
[TBL] [Abstract][Full Text] [Related]
39. Proteolysis regulates exposure of the IIICS-1 adhesive sequence in plasma fibronectin.
Ugarova TP; Ljubimov AV; Deng L; Plow EF
Biochemistry; 1996 Aug; 35(33):10913-21. PubMed ID: 8718884
[TBL] [Abstract][Full Text] [Related]
40. The domains of human fibronectin mediating the binding of alpha antigen, the most immunopotent antigen of mycobacteria that induces protective immunity against mycobacterial infection.
Naito M; Fukuda T; Sekiguchi K; Yamada T
Biochem J; 2000 May; 347 Pt 3(Pt 3):725-31. PubMed ID: 10769176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
